Drug Free Solution (DSOL) Stock Statistics & Valuation Metrics

Drug Free Solution has a market cap or net worth of $113.36K. The enterprise value is $115.45M.

Drug Free Solution has 283,403,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

Drug Free Solution’s return on equity (ROE) is 5.01 and return on invested capital (ROIC) is 501.18%.

The current PE Ratio of Drug Free Solution is ―. Drug Free Solution’s PEG ratio is 1.86.

In the last 12 months, Drug Free Solution had revenue of 805.00 and earned -1.41M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Drug Free Solution pays an annual dividend of ―, resulting in a dividend yield of ―

Drug Free Solution upcoming earnings date is ―, ―.

Drug Free Solution as a current ratio of 0.04, with Debt / Equity ratio of ―

In the past 12 months, Drug Free Solution has paid 0.00 in taxes.

Drug Free Solution EV to EBITDA ratio is -82.76, with an EV/FCF ratio of -275.05.

Drug Free Solution has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of -174817.39%, and net profit margin of -174816.77%.

The average price target for Drug Free Solution is ―, which is 11.43% higher than the current price. The consensus rating is ―